ACHE and Alzheimer disease: The theoretical assumption for the use of acetylcholinesterase inhibitors lies in the finding of a cerebral deficiency in AD of the chemical substance acetylcholine—a neurotransmitter important for memory and thinking—which sends messages from one cell to another and, after having finished its task, it is degraded by the acetylcholinesterase enzyme so that it does not accumulate between cells.